To further demonstrate that c-Kit+ McSCs can produce invasive melanoma, we topically treated c-Kit-CreER:Braf:Pten:Tomato mice with 4-hydroxytamoxifen (4HT-TAM) to induce transgene expression (Fig. 4j). Here, BRAF is linked to melanoma.